February 5, 2018 / 11:06 PM / 5 months ago

BRIEF-BeiGene Announces Commercial Availability Of Vidaza In China

Feb 5 (Reuters) - BeiGene Ltd:

* BEIGENE ANNOUNCES COMMERCIAL AVAILABILITY OF VIDAZA® (AZACITIDINE FOR INJECTION) IN CHINA

* BEIGENE LTD - VIDAZA IS MARKETED IN CHINA BY BEIGENE UNDER AN EXCLUSIVE LICENSE FROM CELGENE CORPORATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below